Get Premium to unlock powerful stock data
OTCPK:CMXC (USA)  
Cell MedX Corp logo

Cell MedX Corp

$ 0.06 0 (0%) 10:09 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 3.66M
Enterprise V:
$ 4.19M
Volume:
-
Avg Vol (2M):
26.26K
Volume:
-
Market Cap $:
3.66M
PE Ratio:
At Loss
Avg Vol (2-Month):
26.26K
Enterprise Value $:
4.19M
PB Ratio:
0
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Cell MedX Corp
NAICS : 325413 SIC : 3845
123 W. Nye Lane, Suite 446, Carson City, NV, USA, 89706
Description
Cell MedX Corp is an early stage development company focused on the discovery, development and, commercialization of therapeutic products for patients with diseases such as diabetes, by developing technologies to help manage the illness and related complications. The company's product portfolio consists of electromedical technologies, ebalance, and others.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.06
Equity-to-Asset -33.46
Debt-to-Equity -0.31
Debt-to-EBITDA -0.86
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -331.58
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 32.56
9-Day RSI 31.02
14-Day RSI 33.56
6-1 Month Momentum % -24.12
12-1 Month Momentum % -60.2

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.03
Quick Ratio 0.03
Cash Ratio 0.02

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -11.9

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -32700
Net Margin % -43750
ROA % -1145.29
ROIC % -129.92
ROC (Joel Greenblatt) % -43600

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -6.4
EV-to-EBITDA -6.42
EV-to-Revenue 2093
EV-to-FCF -8.31
Earnings Yield (Greenblatt) % -15.63

Financials

CMXC's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with OTCPK:CMXC

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.002
EPS (TTM) ($) -0.019
Beta 0.41
Volatility % 60.26
14-Day RSI 33.56
14-Day ATR ($) 0.006657
20-Day SMA ($) 0.07206
12-1 Month Momentum % -60.2
52-Week Range ($) 0.056 - 0.273
Shares Outstanding (Mil) 62.92

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cell MedX Corp Filings

Document Form Filing Date
No Filing Data

Headlines

See More